Jump to main content
Jump to site search


Development of pharmaceutically relevant bio-based intermediates though aldol condensation and Claisen-Schmidt reactions of dihydrolevoglucosenone (Cyrene®)

Abstract

Dihydrolevoglucosenone (Cyrene®) has been successfully utilised as a bio-based platform molecule for the synthesis of pharmaceutically relevant intermediates through aldol condensation reactions. Utilising sustainable synthetic methodologies, the self-aldol condensations reaction of Cyrene was achieved in high purity, with isolated yields of 81.3%. Claisen-Schmidt reactions with a range of aromatic and heteroaromatic aldehydes yielded novel cyrene-based compounds, characterised by single-crystal X-ray diffraction, FT-IR, NMR and MS.

Back to tab navigation

Supplementary files

Publication details

The article was received on 18 Apr 2018, accepted on 23 May 2018 and first published on 25 May 2018


Article type: Communication
DOI: 10.1039/C8GC01227J
Citation: Green Chem., 2018, Accepted Manuscript
  •   Request permissions

    Development of pharmaceutically relevant bio-based intermediates though aldol condensation and Claisen-Schmidt reactions of dihydrolevoglucosenone (Cyrene®)

    L. Hughes, C. R. McElroy, A. C. Whitwood and A. J. Hunt, Green Chem., 2018, Accepted Manuscript , DOI: 10.1039/C8GC01227J

Search articles by author

Spotlight

Advertisements